MoneyWorks4Me

Trimurthi informs about outcome of AGM

15 Sep 2023 Evaluate

Trimurthi has informed that the 29th Annual General Meeting of the company for FY 2022-23 was held on Friday, 15.09.2023 at 11.00 am through Video Conference. In this regard, it has enclosed the following: Summary of proceedings as required under Regulation 30, Part-A of Schedule - III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure -I, Voting results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure -II and Report of Scrutinizer pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4) (xii) of the Companies (Management and Administration) Rules, 2014 as Annexure -III. The Meeting concluded at 11:21 am.

The above information is a part of company’s filings submitted to BSE.

Novelix Pharma Share Price

76.90 2.93 (3.96%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 333.55
Amrapali Industries 36.65
Adani Enterprises 3040.00
Rashi Peripheral 834.10
PDS 371.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: